Table 2.
Disorder/Substances | In Vitro or In Vivo Model | Mode of Action | References | |
---|---|---|---|---|
Adipose Tissue Inflammation | ||||
Delta-tocotrienol, (DT3), and tart cherry anthocyanins (TCA) | 3T3-L1 adipocytes | ↓ | IL-6 secretion and expression from adipocytes Down-regulation of Mip2, and COX-2 mediated via the NFkB |
Harlan et al. [78] |
cyanidin-3-O-glucoside | Murine 3T3-L1 hypertrophic adipocytes | Modulating the expression of the PPAR-ɣ, Inhibiting the inflammatory pathway modulated by NF-κB |
Molonia et al. [79] | |
Pulmonary Artery Hypertension | ||||
Cyanidin-3-O-β-glucoside | Transforming growth factor-β1 (TGF-β1)-mediated human pulmonary arterial smooth muscle cells (SMCs), Pulmonary artery hypertension (PAH) rats |
↓ ↑ ↓ |
IL-6, TNF-α and IL-10 SOD activity MAD Suppressive effect on PAH progression |
Ouyang et al. [80] |
Diabetes | ||||
Padus racemose Anthocyanins | H2 O2 -induced rat insulinoma (INS-1) pancreatic cells damage | inhibiting the activation of p38 MAPK and NF-κB | Liu et al. [81] |
|
Hypercholestrolemia and Hepatic Inflammation | ||||
Black Raspberry (Rubus occidentalis) | Rats fed high-fat and high-choline diets | ↓ ↓ ↓ |
cecal TMA and serum oxidized TMAO, TC, LDL mRNA expression of pro-inflammatory genes including NF-κB, IL-1β, IL-6, COX-2 protein expression of NF-κB and COX-2 in liver tissue |
Lim et al. [82] |
Cancer | ||||
rice bran, cyanidin 3-glucoside | Human prostatic cancer (PC3) cells | ↓ ↑ |
expression of Smad/Snail signaling molecules expression of cell surface protein, E-cadherin Inhibited matrix metalloproteinase-9 and NF-κB Mediating Snail/E-cadherin expression |
Jongsomchai et al. [73] |
Vitis coignetiae Pulliat (Meoru in Korea) | MCF-7 Human Breast Cancer Cells | ↑ | Inhibiting Akt and NF-κB activity Cisplatin (anti-cancer drug) sensitivity |
Paramananthm et al. [72] |
Dark Sweet Cherry (Prunus avium) | MDA-MB-453 breast cancer cells and athymic mice xenografted with MDA-MB-453 breast cancer cells | ↑ | Bax/Bcl-2 ratio Activation of MAPKs ERK1/2 and p38 Down-regulation of total oncogenic and stress-related Akt |
Layosa et al. Noratto et al. [74,75] |
Vitis coignetiae Pulliat (Meoru in Korea) | Hep3B Human Hepatocellular Carcinoma Cells | Inhibition of the activation NF-κB and suppressed the NF-κB-regulated proteins, Inhibition of proliferation, invasion, and angiogenesis |
Kim et al. [76] |
|
Gastric Ulcer | ||||
Dried acai berries extract (Euterpe oleracea) | Ethanol-induced gastric ulcer in rats | ↑ ↓ |
GSH content and GST and CAT activity MPO activity, TNF-a |
Cury et al. [83] |
Neuroinflammation | ||||
Hibiscus sabdariffa L. (Malvaceae) | Streptozotocin-induced Alzheimer’s disease in mice | ↓ ↓ |
TNF-α, IL-6, and IL-1β Elevated MDA and MPO Reverse up-regulation in the amyloidogenic pathway |
El-Shiekh et al. [84] |
Delphinidin | Alzheimer’s disease model in rats | ↓ ↓ |
AChE, APP, and Aβ ROS overproduction in hippocampus |
Heysieattalab et al. [85] |
Portugal Blueberries (Vaccinium corymbosum L) | Mouse microglia N9 cell line | ↓ ↓ ↓ ↑ |
Suppression of NF-kB and STAT1 NO, PGE2, COX-2 TNF-α Intracellular Production of ROS GSH |
Serra et al. [51] |
Cataract | ||||
Cyanidin-3-O-glucoside | High glucose-induced lens epithelial cell (SRA01/04) | Inhibition SRA01/04 cell apoptosis Regulation of the Bcl-2/Bax ratio Suppression of NF-κB activation and subsequent Cox-2 expression |
Song et al. [54] |
↑—increase, ↓—decrease, Aβ—amyloid beta, AChE—acetylcholinesterase, Akt—protein kinase B, APP—amyloid precursor protein, Bax/Bcl—Bcl-2-associated X protein/B-cell lymphoma protein ratio, CAT—catalase, COX—cyclooxygenase, GSH—reduced glutathione GST—glutathione S—transferases, IL—interleukin, MAPK—mitogen-activated protein kinases, MAD—malondialdehyde, Mip2—macrophage inflammatory protein 2, MPO—metalloproteinase NFkB—nuclear-factor κB, PAH—pulmonary artery hypertension, PGE— prostaglandins, PPAR-ɣ—peroxisome proliferator-activated receptors gamma, ROS—reactive oxygen species, SOD—superoxide dismutase, STAT1—signal transducer and activator of transcription 1, TMA-trimethylamine, TMO—trimethylamine-N-oxide.